Analysis of the binding mode of a novel HIF1α inhibitor through molecular modelling.
暂无分享,去创建一个
[1] Sheng Lin,et al. Discovery of a VHL and HIF1α interaction inhibitor with in vivo angiogenic activity via structure-based virtual screening. , 2016, Chemical communications.
[2] S. Garman,et al. Substrate Promotes Productive Gas Binding in the α-Ketoglutarate-Dependent Oxygenase FIH. , 2016, Biochemistry.
[3] Dan J Stein,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.
[4] Duane D. Miller,et al. Benzimidazole analogs as potent hypoxia inducible factor inhibitors: synthesis, biological evaluation, and profiling drug-like properties. , 2014, Anticancer research.
[5] Marcus D. Hanwell,et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.
[6] V. Bernardes-Génisson,et al. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations. , 2012, Organic & biomolecular chemistry.
[7] W. Wong,et al. Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.
[8] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[9] J. Engh,et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.
[10] G. Melillo,et al. Development of HIF-1 inhibitors for cancer therapy , 2009, Journal of cellular and molecular medicine.
[11] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[12] G. Semenza,et al. Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.
[13] Charles H. Graham,et al. Hypoxia-driven selection of the metastatic phenotype , 2007, Cancer and Metastasis Reviews.
[14] S. Kuo,et al. YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] Inhibits Endothelial Cell Functions Induced by Angiogenic Factors in Vitro and Angiogenesis in Vivo Models , 2005, Journal of Pharmacology and Experimental Therapeutics.
[15] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[16] A. Giaccia,et al. HIF-1 as a target for drug development , 2003, Nature Reviews Drug Discovery.
[17] Yu-Chih Liang,et al. YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway. , 2003, Biochemical pharmacology.
[18] G. Semenza. HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.
[19] G. Semenza,et al. HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.
[20] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[21] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[22] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[23] R. Niemans. Exploiting tumor hypoxia for cancer treatment , 2018 .